Advances in the treatment of cutaneous lupus erythematosus.
about
Pathways leading to an immunological disease: systemic lupus erythematosus.JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosus.S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
P2860
Advances in the treatment of cutaneous lupus erythematosus.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Advances in the treatment of cutaneous lupus erythematosus.
@en
type
label
Advances in the treatment of cutaneous lupus erythematosus.
@en
prefLabel
Advances in the treatment of cutaneous lupus erythematosus.
@en
P2093
P2860
P356
P1433
P1476
Advances in the treatment of cutaneous lupus erythematosus.
@en
P2093
P2860
P304
P356
10.1177/0961203316641771
P577
2016-07-01T00:00:00Z